Sandoz, Intas Can't Ditch Merck's Suit Over Generic Emend
A New Jersey federal judge on Thursday refused to strike a patent infringement claim from Merck Sharp & Dohme Corp.'s dispute with Sandoz Inc. and Intas Pharmaceuticals Ltd. over its anti-nausea...To view the full article, register now.
Already a subscriber? Click here to view full article